Algeria vs Luxembourg: Cause of death, by non-communicable diseases, female
Algeria
79.9%
in 2021
Luxembourg
80.0%
in 2021
Algeria rank
42nd
Luxembourg rank
41st
Cause of death, by non-communicable diseases, female over time
- Algeria
- Luxembourg
How they compare
Luxembourg currently reports 80.0% against 79.9% in Algeria, a difference of 0.1%.
Across all 6 years both countries report, Luxembourg has been ahead every year.
Algeria ranks 42nd and Luxembourg ranks 41st of 185 countries.
Luxembourg has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Luxembourg | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 72.8% | 90.3% | 17.6% | Luxembourg |
| 2010s | 81.4% | 88.3% | 6.9% | Luxembourg |
| 2020s | 75.7% | 79.4% | 3.7% | Luxembourg |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Algeria or Luxembourg?
- Luxembourg, at 80.0% against 79.9% in Algeria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Algeria and Luxembourg?
- 0.1%, with Luxembourg ahead.
- How many years of comparable data are there for Algeria and Luxembourg?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Luxembourg rank globally for cause of death, by non-communicable diseases, female?
- Algeria ranks 42nd and Luxembourg ranks 41st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.